Rising Pharma Holding, Inc. recalls Duloxetine DR Capsules USP 60 mg
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit
- Products
-
- Duloxetine DR Capsules USP 60 mg
- Company
- Rising Pharma Holding, Inc.
- Where it was sold
-
Nationwide.
Nationwide
- Units affected
- 233,003 bottles
- About this recall
- Duloxetine DR Capsules USP 60 mg, a) 30 count (NDC 57237-019-30), b) 90 count NDC 57237-019-90 and c) 1000 count (NDC 57237-019-99) bottles, Distributed by: Rising Pharmaceuticals, Inc., East Brunswick, NJ